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The V protein of Sendai virus (SeV) is nonessential for virus replication in cell culture but indispensable for viral
pathogenicity in mice. At the C terminus of the V protein, there are amino acid residues conserved among the members of
the Paramyxovinae subfamily that are clustered in three regions: region I, just downstream of the RNA editing site; and
regions II and III, cysteine-rich zinc-finger-like regions. In the present study, we introduced mutations into the conserved
amino acids and generated nine mutant viruses. All of the viruses had impaired virus replication in mouse lungs and
attenuated virulence in mice. Furthermore, the C-terminal polypeptides fused with glutathione-S-transferase with a mutation
in region I, II, or III all had impaired Zn binding in a 65Zn-binding assay in solution. These results demonstrate that the
conserved amino acids are important for V protein function, probably via protein conformation dependent on Zn binding. One
mutant, SeV V-H318N, had inefficient RNA editing, indicating that the nucleotide that is a part of the codon encoding histidine
at position 318 is conserved for the RNA editing machinery. In addition, to determine the function of the C-terminal extension
of the V protein, which is not translated in recent virulent field isolates, a translational stop codon was introduced to generate
the corresponding short V protein. The mutant virus showed similar virus propagation and pathogenicity, indicating thatINTRODUCTION
Sendai virus (SeV) is a member of the family
Paramyxoviridae, which includes many human and ani-
mal pathogens. It is an enveloped virus containing a
single RNA genome of negative polarity. The SeV ge-
nome is composed of six genes, each of which encodes
structural proteins, including N (nucleocapsid), P (phos-
pho-), M (matrix), F (fusion), HN (hemagglutinin-neura-
minidase), and L (large) proteins. Among the six genes,
the P gene is unique in that it encodes not a single but
multiple proteins. The colinear transcript encodes the P
protein as well as the C, C, Y1, and Y2 proteins; the latter
four proteins are translated in a shifted frame by alter-
native translational starts. The P gene also directs syn-
thesis of accessory mRNAs for the V protein by inserting
a pseudotemplated G residue at a specific editing site.
Consequently, the P and V proteins share the same 317
residues at the amino terminus, while the V protein
possesses a 67-residue unique carboxyl terminus dis-
tinct from that of the P protein (Lamb and Kolakofsky,
2001; Thomas et al., 1988; Vidal et al., 1990)
A recombinant SeV that possesses a mutation to abol-
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172ish the RNA editing, SeV V(), has remarkably attenu-
ated virulence in mice; the virus is eliminated from the
mouse lung at an early stage of infection unlike the
parental SeV [SeV WT (wild-type)], although this virus
can replicate as efficiently as SeV WT can in cell culture
without any significant alterations in viral mRNA tran-
scription, genome replication, or protein synthesis (Kato
et al., 1997a). Although the exact function of the V protein
in virus replication and pathogenicity is not clear, it is
known that the V protein is essential for efficient virus
replication in mice and for viral pathogenesis. For this
function, the 67-residue unique carboxyl terminus of the
V protein (the V unique region) has been shown to be
essential (Delenda et al., 1997; Huang et al., 2000; Kato et
al., 1997b).
The V unique (Vu) region is characterized by a motif
formed by 15 amino acid residues that are highly con-
served in all of the members of the subfamily Paramyxo-
virinae in the family Paramyxoviridae (Fig. 1). They are
clustered in three regions: region I (so named in this
article), which has four continuous amino acids just
downstream of the RNA editing site; region II, which has
five amino acids in the six amino acid sequence, includ-
ing two cysteine residues forming a part of a zinc-finger-
like motif; and region III, which has five dispersed cys-
teines and a proline residue, forming the main part of theC-terminal extension of the V protein is not relevant to viru
Key Words: paramyxovirus; Sendai virus; V protein; Zn b
Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima
734-8551, Japan. Fax: 81-82-257-5159. E-mail: tsaka@hiroshima-u.ac.jp.
doi:10.1006/viro.2002.1516
0042-6822/02 $35.00ogenesis. © 2002 Elsevier Science (USA)
pathogenicity; reverse genetics; conserved amino acid.
zinc-finger-like motif. Their conservation suggests that
they are important for the structure and function of the Vs path
inding;
protein. However, this speculation has not been investi-
gated extensively. We thus introduced mutations into the
conserved residues and generated viruses with these
mutations by using a reverse genetics system. We inves-
tigated the pathogenicity of the mutant viruses in mice
and the Zn-binding capacity of the Vu region.
The V protein of the SeV Hamamatsu strain, a field
isolate of strong virulence, is shorter than that of the Z
strain by early stop codons (Fujii et al., 2001), suggesting
that the C-terminal extension is involved in the low
pathogenicity of the Z strain. Thus, we also investigated
the significance of the C-terminal extension by making a
mutant virus, SeV V-Q370stop, which has a truncated V
protein of the same length as that of the Hamamatsu
strain in the Z strain background.
RESULTS
Mutations in the Vu region of the SeV V protein
Alignment of amino acid sequences of the Vu region
by using the CLUSTALW program (Thompson et al., 1994)
demonstrated that 15 amino acid residues are highly
conserved among the Paramyxovirinae subfamily of vi-
ruses (Fig. 1). Mutations were introduced to examine the
significance of the conserved residues (Fig. 2). All of the
conserved amino acids in region I were individually sub-
stituted with a distinct amino acid, generating V-H318N,
V-R319W, V-R320G, and V-E321K. Two cysteine residues in
region II, which were considered to be a part of a zinc-
finger-like motif, were simultaneously mutated to serine
residues [V  (C337S  C341S), named V-Cys I]. Other
conserved residues in region II were also individually
mutated, generating V-W336G and V-P339T. Three con-
served cysteine residues of the five cysteine residues in
region III were simultaneously mutated [V (C353R 
C355R  C358S), V-Cys II], and the other two cysteine
residues were also mutated [V  (C362S  C365R), V-Cys
III]. All of the mutations were designed not to change
amino acid residues of the overlapping P-coding frame,
and an amino acid residue with a more conservative
nature was selected when multiple candidates were
possible.
In addition, to determine whether the extra C-terminal
extension of the Z strain is involved in viral pathogenicity,
glutamine at position 370 was substituted with a trans-
lation termination signal (V-Q370stop) (Fig. 2).
Zn-binding capacity of the mutant Vu proteins
Vu polypeptides are characterized by Zn binding at the
zinc-finger-like motif composed of seven conserved cys-
teine residues (Paterson et al., 1995; Liston and Briedis,
1994; Steward et al., 1995). We previously demonstrated
by generating mutant viruses each possessing a substi-
FIG. 1. Multiple amino acid sequence alignment of the Vu regions of the Paramyxovirinae subfamily viruses. The Vu regions of selected members
of the Paramyxovirinae subfamily were aligned using the CLUSTALW program (DNA Data Bank of Japan). The sequence of SeV is at the top, and
sequences closer to that of SeV were aligned from top to bottom. Conserved amino acid residues are in boldface and marked by asterisks, and
cysteine residues in the conserved residues are further shaded. DDBJ/EMBL/GenBank accession numbers are shown in parentheses. SeV, Sendai
virus; BPIV3, bovine parainfluenza virus type 3; TPMV, Tupaia paramyxovirus; SLMV, Salem virus; HeV, Hendra virus; PDV, phocine distemper virus;
PPRV, Peste-des-petits-ruminants virus; DMV, dolphin morbillivirus; MeV, measles virus; RPV, rinderpest virus; HPIV4A, human parainfluenza virus type
4A; HPIV4B, human parainfluenza virus type 4B; NDV, Newcastle disease virus; MuV, mumps virus; SV5, simian virus 5; SV41, simian virus 41; HPIV2,
human parainfluenza virus type 2.
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tution of the conserved cysteine residues that the Zn-
binding capacity of the V protein is correlated with viral
pathogenicity (Huang et al., 2000). We speculated from
the results of that study that the V protein conformation
depends on Zn binding, in turn affecting its unknown
function related to viral pathogenicity. Thus, Zn-binding
capacity could be an indicator of the V protein confor-
mation.
We therefore examined the Zn-binding capacities of
the mutant proteins. Mutant Vu polypeptides fused with
glutathione-S-transferase (GST) were expressed in Esch-
erichia coli and affinity-purified. The proteins, GST-Vu-
WT, GST-Vu-R319W, GST-Vu-Cys I, and GST-Vu-Cys III,
were analyzed by sodium dodecyl sulfate (SDS)–polyac-
rylamide gel electrophoresis (PAGE) and blotted onto a
membrane. The membrane was then incubated with
65ZnCl2 subjected to radioautography and subsequent
staining by amido black 10B (Fig. 3A). Besides full-length
GST-Vu proteins, dense extra bands with migrations sim-
ilar to GST and between GST-Vu and GST were observed.
They were thought to have been generated by pretermi-
nation of translation due to unmatched codon usage in E.
coli. However, efficient Zn binding was observed only in
full-length GST-Vu proteins (Fig. 3A), indicating that these
proteins were usable for a subsequent quantitative Zn-
binding assay.
We thought that zinc blots, as shown in Fig. 3A, were
not suitable for a quantitative assay for Zn binding, and
we used a more rigorous Zn-binding assay instead. Pro-
teins were incubated with 65ZnCl2 in solution and later
isolated from unbound Zn ions by gel filtration. The pro-
tein fractions (void fractions) were measured for radio-
activity using a gamma counter and subsequently sub-
jected to SDS–PAGE and silver staining for quantification
of full-length GST-Vu proteins. Radioactivity standardized
with protein amounts is considered to represent
amounts of Zn ions bound to proteins. In this assay,
conditions such as concentration of Zn ions, solution of
pH, and molecular weight cutoff of gel filtration were
critical for reproducible results, since Zn ions tend to
bind hydroxide ions and form aggregations in solution,
especially in solution of high pH.
The experiments were repeated three times, and the
results were plotted in a graph (Fig. 3B). A Zn-binding
protein, carbonic anhydrase, showed a constant value.
GST-Vu-R319W as well as multicysteine mutants, GST-Vu-
Cys I and GST-Vu-Cys III, showed low degrees of Zn-
binding capacity compared with that of GST-Vu-WT, indi-
cating that a mutation in region I, other than mutations in
the zinc-finger-like motif, impaired the Zn-binding capac-
ity of the Vu polypeptide. These mutations may all affect
V protein conformation.
Recovery of SeV possessing the mutant V proteins
from cDNA
Live SeVs possessing each of the mutations were
recovered from cDNA by using a virus recovery system.
Recovery efficiencies of the mutant viruses were almost
equivalent to that of the control SeV WT (data not shown),
and virus infectivities after incubation in eggs at 32°C for
3 days to prepare seed stock viruses ranged from 109 to
1010 cell infectious units (CIU)/ml, indicating that the virus
growth rates of the mutant viruses in embryonated
chicken eggs were similar.
Protein synthesis of the SeV V mutant viruses in
cultured cells
To analyze protein synthesis of the SeV V mutants,
LLC-MK2 cells were infected with the mutants at a mul-
tiplicity of infection (m.o.i.) of 20, and proteins were la-
beled with [35S]cysteine-methionine for 30 min and im-
munoprecipitated with either anti-V, anti-SeV, or anti-C
antiserum (Fig. 4A). Anti-V antiserum precipitated both V
and P proteins, since the N-terminal halves are common
between the two proteins (Fig. 4A, V). The amounts of
FIG. 2. Schematic representation of mutations of the SeV V protein. Mutations were introduced into the conserved amino acids in the Vu region
(shadowed) so as not to change any amino acids of the overlapping P-coding frame. Cys I: C337S  C341S; Cys II: C353R  C355R  C358S; Cys III: C362S
 C365R. *: stop codon.
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the V protein were measured in three independent ex-
periments, standardized with those of the P protein in the
same lane, and plotted in a graph (Fig. 4B). This graph
shows that SeV V-H318N has a smaller amount (approxi-
mately 50% less) of the V protein than that of SeV WT,
while the other mutant viruses have almost equivalent
amounts of V proteins. Although it appears that SeV
V-Cys II also had a smaller amount of V protein, as
shown in Fig. 4A V, this was observed only in this gel
and may be an artifact, probably due to a low input
infectivity as suggested by the low expression levels of
SeV structural proteins in this mutant (Fig. 4A, SeV).
There were no significant differences between the syn-
theses of the C protein by the viruses (Fig. 4A, C).
The V protein in the SeV V-Q370stop-infected cells mi-
grated faster in the gel, indicating truncation of the V
protein as expected (Fig. 4C). There was no difference
between the expression levels of the V protein or the
structural proteins in SeV V-Q370stop and SeV WT (Figs.
4B and 4C).
RNA editing efficiency to generate V mRNA of the
mutant viruses
Protein analysis showed that the mutant virus SeV
V-H318N had a smaller amount of the V protein in the
virus-infected cells. This virus had a single base substi-
tution in the genome from G to U just after the charac-
teristic sequence of the editing site, 3-UUUUUUCCC-5.
Since this may have altered RNA editing efficiency, we
analyzed edited RNA contents by limited primer exten-
sion using an assay primer that annealed just upstream
of the UUUUUU run. Total RNA was extracted from virus-
infected LLC-MK2 cells and used as a template for re-
verse transcription (RT)-polymerase chain reaction (PCR)
to amplify DNA fragments corresponding to a region of
mRNA around the RNA editing site. By using the product
as a template, primer extension was performed in the
presence of an assay primer, dATP, dCTP, [-32P]dGTP,
and ddTTP (Fig. 5A). In this assay, DNA templates de-
rived from the colinear transcripts and those from edited,
one-G-inserted transcripts were demonstrated as 0G
and 1G bands, respectively (Fig. 5).
Radioactivity of the bands was quantified and stan-
dardized by the number of G residues, and percentage
ratio of radioactivity of1G against the sum of0G plus
1G was calculated (Fig. 5B). Only the 1G band to
generate the V mRNA was analyzed in the present study,
although a small fraction (7%) of mRNA inserted with
two or more G nucleotides has been reported (Vidal et
al., 1990). The ratio of the 1G band in SeV WT-infected
cells was 34%, which is almost the same as that reported
previously (Vidal et al., 1990). The ratio of the 1G band
in SeV V-H318N was only 10%, while the ratios in the other
mutant viruses were similar (28 to 36%), indicating im-
pairment of RNA editing by the H318N mutation. The 1G
band was not found in SeV V()-infected cells, indicating
authenticity of the assay system (Fig. 5B). In this assay,
viral antigenomic RNA also contributed to the unedited
values that were seen, since total RNA, not poly(A)
RNA, was used as a template for RT-PCR. However, the
contribution is presumed to be small and ignorable since
editing efficiency is almost the same as that previously
reported (Vidal et al., 1990).
Replication of SeV V mutants in cultured cells
To determine the effects of the introduced mutations
on virus replication in cell culture, LLC-MK2 cells were
FIG. 3. Western blotting of the mutant GST-Vu proteins and quantifi-
cation of their Zn-binding capacities. (A) Mutant GST-Vu proteins [V
unique polypeptide (318–384) fused with GST] as well as GST were
resolved by SDS–PAGE and transferred onto a membrane. The blot was
probed with 65ZnCl2 to detect Zn binding and processed for autoradiog-
raphy (65Zn-binding). The membrane was then stained by amido black
10B to detect blotted proteins (Amido Black). (B) Zn-binding capacities
of the GST-Vu mutants. The GST-Vu mutant proteins, including a zinc-
binding protein, carbonic anhydrase (CA), were incubated with 65ZnCl2
in a buffer at pH 6.5 for 18 h and subjected to gel filtration using a spin
column. For a protein (void) fraction, radioactivity was measured and
proteins in the fraction were analyzed by SDS–PAGE and silver stain-
ing, and the Zn-binding capacity was standardized by a protein content.
The ratio of Zn binding of the GST-Vu mutants to that of the wild-type
GST-Vu was calculated using data obtained from three independent
experiments and is shown in the graph.
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infected with these mutants at an m.o.i. of 0.01. Although
all of the mutants had initially replicated slightly faster
than had SeV WT on Day 2, the peak titers on Day 3 were
equivalent (Fig. 6). These results demonstrate that the
replication of SeV-V mutants was similar to that of the
parental SeV WT in cultured cells. Thus, these mutations
in the V protein did not have any detrimental effects on
virus replication in cell culture.
Replication of SeV V mutants in mouse lungs
We next investigated virus replication of the selected
mutants in the mouse lung. Three-week-old ICR mice
were infected with 107 CIU/mouse of the SeV V mutants,
and the time course of virus replication in the mouse
lung was investigated (Fig. 7). The rate of replication of
SeV V-R319W was similar to that of SeV WT on Day 1, but
SeV V-R319W later rapidly cleared from the mouse lung,
although there was a temporary peak on Day 5. The rate
of replication of SeV V-E321K was intermediate between
that of SeV V-R319W and that of SeV WT. The rate of
replication of SeV V-P339T was almost the same as that of
SeV WT until Day 2, but SeV V-P339T later cleared from the
mouse lung (Fig. 7). These single-residue mutants in
regions I and II replicated poorly compared with the
replication of SeV WT (Fig. 7).
The rates of replication of SeV V-Cys I, SeV V-Cys II,
and SeV V-Cys III were almost the same as that of SeV
WT from Day 0 to Day 3 but decreased thereafter, while
SeV WT further replicated efficiently, generating a sec-
ond peak on Day 5 (Fig. 7). Cysteine mutants were all
defective in efficient virus growth in mouse lungs. In
contrast to the viruses described above, SeV V-Q370stop
showed virus growth identical to that of SeV WT (Fig. 7).
Pathogenicity of SeV-V mutants to mice
Five mice in a group were infected with a dilution of a
mutant virus. The mice were observed over a period of 2
weeks after infection, and 50% mouse lethal dose
FIG. 4. (A) Protein syntheses of SeV V mutants in cultured cells. LLC-MK2 cells were infected with SeV V mutants as well as SeV WT at an m.o.i.
of 20. Proteins were labeled with [35S]cysteine-methionine for 30 min at 7 h postinfection and immunoprecipitated with either anti-V serum (V),
anti-SeV serum (SeV), or anti-C serum (C). Proteins were analyzed by SDS–PAGE and processed for autoradiography. F0: precursor of the F protein.
(B) Quantification of the V protein. Radioactivity of the V protein was standardized with that of the P protein in the same lane and compared with that
of SeV WT, which was set at 1.0. The mean and standard deviation from three experiments are shown in the graph. (C) Protein synthesis of SeV
V-Q370stop in cultured cells. LLC-MK2 cells were infected with SeV V-Q370stop as well as SeV WT, and proteins were precipitated with either anti-V
serum (V) or anti-SeV serum (SeV) as described above.
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(MLD50) values of the mutant viruses were determined
(Table 1). Relative pathogenicities were also calculated
as ratios of reciprocals of MLD50 values to that of SeV WT
as described under Materials and Methods. The single
amino acid mutants in regions I and II and SeV cysteine
mutants all had attenuated virulence, probably due to
their inefficient replications in mouse lungs as shown in
Fig. 7. SeV V-P339T had relatively high pathogenicity (0.64
of SeV WT), but others had 0.01 to 0.1 of relative patho-
genicity. In contrast, SeV V-Q370stop, whose rate of rep-
lication in the mouse lung was similar to that of SeV WT
(Fig. 7), was as pathogenic as SeV WT (Table 1).
DISCUSSION
The V protein of paramyxoviruses has been shown to
bind Zn ions. The V protein of simian virus 5 has been
shown to bind two Zn atoms per molecule (Paterson et
al., 1995), and the V protein fused with GST and ex-
pressed in E. coli has been shown to bind Zn in measles
virus and Newcastle disease virus (Liston and Briedis,
1994; Steward et al., 1995). GST-Vu polypeptides of SeV
have also been shown to bind Zn ions (Huang et al.,
2000). GST-Vu mutant proteins possessing a mutation at
one of the seven conserved cysteines showed lower
extents of 65Zn binding in zinc blots than that of the
wild-type, indicating involvement of the cysteine residues
in Zn binding. Two cysteine mutant viruses, SeV V-C341S
and SeV V-C365R, had attenuated virulence with relative
pathogenicities of 0.03 and 0.1, respectively, of that of SeV
WT (Huang et al., 2000). These show that Zn-binding
capacity of the V protein is related to virus pathogenicity
and suggest that Zn binding can be an indicator of the V
protein conformation and function. To confirm this sug-
gestion and in expectation of obtaining a more attenu-
ated virus, we introduced multiple mutations into the
conserved cysteine residues. As expected, GST-Vu-Cys I
(C337S and C341S) and GST-Vu-Cys III (C362S and C365R) had
low degrees of Zn-binding capacity in a Zn-binding assay
in solution, and the viruses possessing the V-Cys I, V-Cys
FIG. 5. Limited primer extension. Total RNA was extracted from
SeV-infected cells, and DNA fragments spanning the RNA editing site
were amplified from the positive RNA strand by RT-PCR to prepare a
template for primer extension. (A) Oligonucleotides were primed by an
assay primer (arrow), synthesized by incorporation of deoxyadenosine
(A), deoxycytidine (C), and 32P-labeled deoxyguanosine (G*), and termi-
nated by incorporation of dideoxythymidine (T). 0G is an oligonucle-
otide synthesized from the nonedited colinear transcript, and 1G is
that from the edited, one-nucleotide-inserted transcript. The U-and-C
run characteristic of the RNA editing site is boxed. (B) Oligonucleotides
synthesized were analyzed using an 8% sequencing gel and radioau-
tography. The SeV V mutants employed include SeV V(), in which the
editing site is destroyed by two-base substitutions and in which no
RNA editing occurs (Kato et al., 1997a). Percentage ratio of radioactivity
of 1G against the sum of 0G plus 1G is shown below the lane.
FIG. 6. Replication of SeV V mutants in cultured cells. LLC-MK2 cells were infected with each of the SeV V mutants at an m.o.i. of 0.01 and incubated
in Dulbecco’s modified MEM in the presence of 10 g/ml trypsin. A part of the culture medium was sampled daily and infectivity was measured.
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II (C353R  C355R  C358S), and V-Cys III mutations were
attenuated with relative pathogenicities of 0.04, 0.02, and
0.04, respectively. GST-Vu-R319W, which possesses a sin-
gle mutation in the conserved amino acids in region I,
also had a lower degree of Zn-binding capacity. Although
we analyzed only one mutation, a mutation in region I,
which is distant from the zinc-finger-like domain and
seemingly unrelated to Zn binding, it was actually
thought to be involved in Zn binding.
All of the mutations of the conserved residues of the
Vu region, including V-R319W, rendered SeV unable to
replicate efficiently in the mouse lung, leading to atten-
uated virulence to mice. The conserved amino acids are
therefore important for the function of the V protein; they
enhance virus growth in the mouse lung and viral patho-
genicity to mice. It is thought that these residues are
involved in maintenance of the conformation of the V
protein.
Efficiency of RNA editing was reduced by more than
half in the H318N mutation in which a G residue just
downstream of the template, 3-UUUUUUCCC-5, was
changed into a U residue (3-UUUUUUCCCG was
changed to 3-UUUUUUCCCU). Thus, attenuated viru-
lence of SeV V-H318N may be due to a small amount of the
V protein in infected cells as well as possible invalid
protein conformation by the mutation. Hausmann et al.
(1999a,b) analyzed the cis-acting signals controlling ed-
iting efficiency and the number of inserted nucleotide
residues in the SeV P gene, and they found that the
nucleotide residues just upstream of the 3-UUU-
UUUCCC-5 run are important for modulating the pattern
of G insertions. They speculated that stability of the
template–polymerase complex at the purine run is im-
portant for the event. However, they did not analyze
downstream residues. The present results indicate that
the nucleotide residue just downstream also controls
efficiency of RNA editing. In this case, there is a possi-
bility that the template forms some kind of structure,
including the downstream residue of the U-and-C run for
RNA editing.
Hamamatsu and Oh-ita strains, virulent field strains
recently isolated in Japan, each possess a truncated V
protein unlike other avirulent laboratory strains such as
the Z and Fushimi strains (Fujii et al., 2001; Itoh et al.,
1997). We speculated that the C-terminal extension that
includes two additional cysteine residues inhibits the V
function as in the case of the inactive HN0 precursor of
Newcastle disease virus, in which the C-terminal
polypeptide elongation inhibits the protein function (Na-
gai and Klenk, 1977). To investigate this possibility, a stop
TABLE 1
MLD50 Values of SeV V Mutants
a
Virus
MLD50 (relative pathogenicity)
Experiment 1 Experiment 2
SeV WT 7.9 105 (1.00) 3.2 105 (1.00)
SeV V-H318N 2.0 10
7 (0.04) ND
SeV V-R319W 2.0 10
7 (0.04) ND
SeV V-R320G 1.3 10
7 (0.06) ND
SeV V-E321K 7.9 10
6 (0.10) ND
SeV V-W336G 1.3 10
7 (0.06) ND
SeV V-P339T ND 5.0 10
5 (0.64)
SeV V-Cys I ND 7.9 106 (0.04)
SeV V-Cys II ND 1.3 107 (0.02)
SeV V-Cys III ND 7.9 106 (0.04)
SeV V-Q370stop ND 3.2 10
5 (1.00)
a Values are MLD50 values of SeV V mutants (CIU/mouse) in two
experiments. Relative pathogenicity, the ratio of the reciprocal of the
MLD50 value to that of SeV WT, (MLD50 of SeV WT)/(MLD50 of a virus),
is shown in parentheses. ND, not done. Cys I, C337S  C341S; Cys II,
C353R  C355R  C358S; Cys III, C362S  C365R.
FIG. 7. Replication of SeV V mutants in the mouse lung. Mice were infected with 107 CIU/mouse of each of the SeV V mutants as well as SeV WT,
and two or three mice infected with each of the viruses were sacrificed on Days 0, 1, 2, 3, 5, 7, and 9. The lungs were removed from each mouse and
homogenized in 1 ml of MEM, and then infectivity was measured. Each point represents the mean infectivity in the mice. The lungs of mice that died
on Day 8 were removed on that day.
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codon was introduced to generate a similarly truncated V
protein in the SeV Z (WT) background. The virus showed
a growth comparable with that of SeV WT in vitro and in
vivo and had pathogenicity similar to that of SeV WT,
suggesting dispensability of the region. This may be
consistent with the fact that the C-terminal region does
not have any residues conserved among the Paramyx-
ovinae subfamily.
The V protein has various functions in paramyxovi-
ruses. The V-deficient Newcastle disease virus shows
impaired growth in cell culture and embryonated eggs,
indicating that the V protein is essential for virus repli-
cation in vitro and in ovo (Mebatsion et al., 2001), while
the SeV V protein appears to be necessary only in vivo
(Kato et al., 1997a). The V protein of simian virus 5
counteracts a response to interferon by causing a STAT1
degradation (Didcock et al., 1999; Komatsu et al., 2000),
and the V protein of human parainfluenza type 2 does so
by destabilizing STAT2 (Kawano et al., 2001; Nishio et al.,
2001; Parisien et al., 2001). This anti-interferon action has
been shown to depend mainly on the Vu region, although
involvement of an amino acid in the P/V common region
has also been shown (Young et al., 2001). Complete
conservation of the 15 amino acids in the Vu region
among these viruses does not explain the functional
divergence. This functional divergence therefore may be
due to nonconserved amino acids in the Vu region,
whereas the conserved amino acids may provide the
basic structure of the protein.
The mechanism of acceleration of SeV replication in
vivo by the V protein is not known. The V protein of
simian virus 5 interacts with damaged DNA-binding pro-
tein, and the cell cycle is controlled by this interaction
(Lin and Lamb, 2000; Lin et al., 1998). In that case, a
single mutation at the conserved cysteine residues abol-
ished the interaction, suggesting that the V protein con-
formation is dependent on the cysteine residues. Our
study showed that virus pathogenesis, related to the V
function, was also dependent on the cysteine residues
and other amino acids. We speculate that the V protein
interacts with a host factor via a protein conformation
constructed by the conserved residues for this function.
Further study is needed to determine the host factor that
interacts with the SeV V protein.
MATERIALS AND METHODS
Cells, viruses, and antibodies
LLC-MK2 cells were grown in Eagle’s minimal essen-
tial medium (MEM) supplemented with 10% fetal calf
serum. SeV WT, which was derived from cDNA of the Z
strain, and its mutants were propagated in embryonated
chicken eggs. Infectivity was measured by an immuno-
fluorescent infectious focus assay and expressed as cell
infectious units/ml (Kashiwazaki et al., 1965). A vaccinia
virus expressing T7 RNA polymerase, vTF7.3 (Fuerst et
al., 1986), was kindly provided by Bernard Moss (National
Institutes of Health, Bethesda, MD) and propagated in
CV1 cells.
An anti-SeV antibody was prepared by immunizing
rabbits with purified SeV virions, and antibodies against
the V and C proteins were kindly provided by Atsushi
Kato (National Institute of Infectious Diseases, Japan).
Recovery of SeV-possessing mutations in the V
protein
DNA manipulations were performed basically accord-
ing to a manual (Ausubel et al., 1998). The pSeV()
plasmid (Kato et al., 1996), which has the entire genomic
cDNA of the SeV Z strain flanked by a modified T7
promoter and the hepatitis delta virus ribozyme, was
introduced into E. coli JM110 (dam, dcm) to eliminate
DNA methylation and was then cut by a methylation-
sensitive restriction enzyme, ClaI. A ClaI fragment from
pSeV(), corresponding to nucleotides 2090 to 5335 in
the SeV antigenomic cDNA, was subcloned into pHSG396.
Site-directed mutagenesis was performed on the plas-
mid using a QuickChange mutagenesis kit (Stratagene,
La Jolla, CA). All of the mutants were screened by se-
quence analysis using a 310 genetic analyzer (PE Bio-
systems, Foster City, CA). The mutated ClaI fragments
were then returned to pSeV().
SeV was recovered from the recombinant plasmids as
described previously (Kato et al., 1996). Briefly, vTF-7.3-
infected LLC-MK2 cells were transfected with the mutant
pSeV() together with pGEM-N, pGEM-P, and pGEM-L.
Embryonated chicken eggs were inoculated with the cell
lysates and incubated at 32°C for 3 days.
Expression of the GST-Vu fusion protein and
Zn-binding assay
Vu polypeptides fused with GST were synthesized as
described previously (Huang et al., 2000) with some
modifications. Mutated Vu cDNA fragments, correspond-
ing to the polypeptide from His at position 318 to Ser at
position 384, were amplified from the mutant pSeV()
plasmids by PCR and inserted into a GST fusion expres-
sion vector, pGEX-4T-1 (Amersham Pharmacia Biotech,
Piscataway, NJ), between the BamHI and XhoI sites. The
recombinant plasmids, confirmed by sequence analysis,
were introduced into BL21-CodonPlus-RIL cells (Strat-
agene), and then recombinant protein expression was
induced and the cells were collected by centrifugation.
The cells were lysed by using BugBuster lysis buffer and
Benzonase nuclease (Novagen, Madison, WI), and the
lysates were applied to a glutathione-Sepharose 4B af-
finity chromatography column and further eluted with
glutathione. Protein was quantified using a Bradford pro-
tein assay.
Western blotting and Zn blots were performed as de-
scribed previously (Huang et al., 2000). Briefly, proteins
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were resolved by SDS–PAGE using a 15% gel and blotted
onto a PVDF membrane. The membrane was then incu-
bated in 100 mM Tris–HCl, pH 6.8, 50 mM NaCl, and 370
kBq/ml 65ZnCl2 (NEN Life Science Products, Boston, MA),
washed with 100 mM Tris–HCl, pH 6.8, 50 mM NaCl, and
1 mM dithiothreitol (DTT), and processed for radioautog-
raphy by using a BAS2000 image analyzer (Fuji Film,
Tokyo, Japan). The membrane was further stained with
amido black 10B to visualize blotted proteins.
For a Zn-binding assay in solution, purified proteins
were incubated in a 50-l mixture of 80 mM 2-(N-mor-
pholino)ethanesulfonic acid (MES), pH 6.5, 40 mM NaCl,
1 mM DTT, and 20 M (97 kBq/ml) 65ZnCl2 at room
temperature for 18 h. The reaction conditions were
based on those described in a previous article (Singh et
al., 1989). The sample was then loaded onto a CROMA
SPIN-30 column (Clontech, Palo Alto, CA) preequilibrated
with 10 mM MES, pH 6.5, 140 mM NaCl, and 1 mM DTT.
After centrifugation at 700 g for 5 min, a void fraction was
measured for -ray radioactivity by using an Auto Well
Gamma System ARC-380 (Aloka, Tokyo, Japan). All of the
proteins in the fraction were then analyzed by 15% SDS–
PAGE and stained by silver straining. The density of the
full-length GST-Vu band was quantified by using an FX
Molecular Imager (Bio-Rad Laboratories, Hercules, CA)
as described previously (Sakaguchi et al., 2002).
Protein analysis by metabolic labeling and
immunoprecipitation
Confluent monolayers of LLC-MK2 cells in a 35-mm
dish were infected with SeV at an m.o.i. of 20. After 7 h,
the cells were labeled with [35S]cysteine-methionine
([35S]Pro-mix; 3.7 MBq/ml; Amersham Pharmacia Bio-
tech) for 30 min in methionine- and cysteine-free Dulbec-
co’s modified MEM. The cells were lysed in radioimmu-
noprecipitation assay buffer (10 mM Tris–HCl, pH 7.4, 1%
Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 150 mM
NaCl). Polypeptides were immunoprecipitated with ei-
ther anti-SeV, anti-V, or anti-C serum and analyzed by
SDS–PAGE as described previously (Sakaguchi et al.,
1991). An autoradiogram was analyzed by using an im-
age analyzer.
Limited primer extension of the V mRNA in infected
cells
The protocol used was basically the same as that
described by Hausmann et al. (1999a). LLC-MK2 cells in
a 35-mm dish were infected with SeV at an input m.o.i. of
10 and incubated in MEM for 24 h. Total RNA was
extracted from the infected cells by using ISOGEN re-
agent (Nippon Gene, Tokyo, Japan) according to the
manufacturer’s instructions and was then reverse-tran-
scribed with a VedR primer (5-TTGAGCAGTTGTTTGT-
TCTC-3) by using Superscript II reverse transcriptase
(Invitrogen, Carlsbad, CA) at 42°C for 30 min. PCR was
carried out in a 50-l reaction mixture containing the
VedR primer, a VedN primer (5-CAATAGGGACCCGC-
TCTGTC-3), and Taq DNA polymerase. The PCR product
(316 bp) was purified by agarose gel electrophoresis and
used as a template for primer extension.
Limited primer extension was carried out at 37°C for 2
min in a 15-l reaction mixture containing 1 g alkali-
denatured PCR products, 1 pmol of an assay primer
(5-GGTCTAGAGACCGACTCAAC-3), 27 mM Tris–HCl,
pH 7.5, 14 mM MgCl2, 33 mM NaCl, 7 mM DTT, 10 M
dATP, 10 M dCTP, 2 M ddTTP, 18.5 kBq/l [-32P]dGTP
(Amersham Pharmacia Biotech), and 3 U modified T7
DNA polymerase. The assay primer was designed to
anneal just upstream of the 3-TTTTTTCCC-5 stretch of
the PCR product. Then the reaction was chased by ad-
dition of 75 nmol dNTP and further incubated at 37°C for
2 min. After addition of 18 l of a stop solution (95%
formamide, 20 mM EDTA, 0.05% bromphenol blue, and
0.05% xylene cyanol FF), a part of the sample (3 l) was
resolved by an 8% sequencing gel, and radioactivity was
analyzed using an image analyzer.
Replication of SeV mutants in cultured cells
Confluent LLC-MK2 cells were infected with SeV at an
m.o.i. of 0.01 and maintained in Dulbecco’s modified
MEM containing 10 g/ml of crude trypsin as described
previously (Sakaguchi et al., 1997). A part of the culture
medium was sampled daily, and infectivity was mea-
sured.
Infection of mice with SeV
Specific pathogen-free 3-week-old male mice of the
ICR/Crj (CD-1) strain, purchased from Charles River Ja-
pan (Atsugi, Japan), were intranasally inoculated with
either 105, 106, 107, or 108 CIU of SeV per mouse under
mild anesthesia with ether, and their body weights and
clinical symptoms were checked daily over a period of 2
weeks. Based on the lethality of mice, MLD50 values
were calculated as described previously (Huang et al.,
2000). Pathogenicity was defined as the reciprocal of the
MLD50 value, and relative pathogenicity was a ratio of the
pathogenicity of a virus to that of SeV WT in the equation
(MLD50 of SeV WT)/(MLD50 of a virus). In experiments to
investigate virus replication, infected mice were sacri-
ficed at certain time intervals and their lungs were ho-
mogenated in 1 ml MEM per mouse; then virus infectivity
was measured. All of the mice were kept in a bioclean
condition in the facility for animal experiments of Hiro-
shima University School of Medicine.
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